Table 3.
Patents related to therapeutic uses of quercetin.
| S. No. | Patent Publication Number | Title of the Patent | Activity and Application | Reference |
|---|---|---|---|---|
| 1. | US20040161247A1 | Therapeutic agent for osteoporosis comprising an active ingredient of quercetin derivatives | The present invention relates to a therapeutic agent for osteoporosis, which comprises an active ingredient of quercetin derivatives. | [60] |
| 2. | US8440704B2 | Quercetin-containing compositions | This invention relates to a composition containing quercetin, vitamin B3, and vitamin C. | [61] |
| 3. | JP3896577B2 | Quercetin glycoside composition and preparation method | Preparation of compounds containing saccharide radicals produced by the action of a beta-amylase, e.g., maltose. | [62] |
| 4. | AU2012340840B2 | Method for treating hepatitis C virus infection using quercetin-containing compositions | Heterocyclic compounds having nitrogen as a ring hetero atom, e.g., guanethidine. | [63] |
| 5. | WO2009045735A2 | Method for stabilizing quercetin | This invention relates to a method for stabilizing quercetin by placing it in a solution containing vitamin B3 and vitamin C and assessing the stability of the quercetin in the mixture. | [64] |
| 6. | CA2735826C | Reducing cholesterol levels with combined use of quercetin and statin | The use of a first composition containing quercetin, vitamin C, and vitamin B3, and a second composition containing a statin and a pharmaceutically acceptable carrier, for reducing the plasma cholesterol level in a subject is described. | [65] |
| 7. | CN103145669A | Process of clean production of quercetin | Process of clean production of quercetin. | [66] |
| 8. | US6562866B1 | Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin | Method for treating or preventing an elevated blood lipid level-related disease in a mammal, which comprises administering thereto an effective amount of rutin, quercetin, or a mixture thereof. | [67] |
| 9. | US5445842A | Quercetin-containing coloring | A quercetin-containing colorant that has, as an effective component, a quercetin that is included by cyclodextrin. | [68] |
| 10. | CN101111244B | Composition for promoting production of hyaluronic acid containing kaempferol and quercetin | Disclosed is a composition for promoting the production of hyaluronic acid containing at least one of kaempferol and quercetin. | [69] |
| 11. | CN104817603A | Method for preparing quercetin-3-O-beta-D-glucuronide from lotus seedpod | The invention relates to a method for preparing quercetin-3-O-beta-D-glucuronide from lotus seedpod. | [70] |
| 12. | US7049301B2 | Quercetin derivatives and their medical usages | This invention relates to quercetin derivative, its preparation, and a pharmaceutical combination, as well as their medical uses for the prevention or treatment of diseases. | [71] |
| 13. | US9289444B2 | Composition for promoting hematogenesis containing quercetin 3-O-β-(2″-galloyl)-rhamnopyranoside as active ingredient | This invention relates to a composition for promoting hematopoiesis and for treating, preventing, or alleviating cytopenia or bone marrow failure comprising quercetin 3-O-β-(2″-galloyl)-rhamnopyranoside (QGR) as active ingredient. | [72] |
| 14. | CN101955514A | Method for synthesizing agarose gel hydrogen bond adsorbing chromatography medium by using quercetin as genin | The invention relates to a method for synthesizing a hydrogen bond adsorbing medium by taking agarose gel as a matrix and taking quercetin as genin. | [73] |
| 15. | TWI618573B | A quercetin-type surfactant, its preparation method and application. | The invention prepares a natural quercetin-type surfactant and uses the quercetin and the diol compound to synthesize a quercetin derivative under an acidic catalyst. | [74] |
| 16. | US20080031940A1 | Quercetin-containing composition, methods of making, and methods of using | The composition is a sustained release composition in tablet or capsule form suitable for oral administration to a human. Methods of making and using the composition are provided. | [75] |
| 17. | RU2745123C1 | Bioactive composition based on a cross-linked hyaluronic acid salt containing resveratrol and a method of its preparation a method for its preparation | Bioactive composition based on a cross-linked hyaluronic acid salt containing quercetin and a method for its preparation. | [76] |
| 18. | CN106822085B | Application of oncolytic adenovirus expressing TRAIL and quercetin in inhibition of liver cancer cell proliferation | Application of oncolytic adenovirus expressing TRAIL and quercetin in inhibition of liver cancer cell proliferation. | [77] |